Fleebs-Logo
Details werden geladen...

Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates | The Manila Times

~ Collaboration will leverage the RaniPill® platform to explore oral delivery of PegBio's proprietary portfolio of novel obesity and metabolic disease molecules ~

Ähnliche Seiten

https://www.manilatimes.net/2026/05/18/tmt-newswire/globenewswire/regeneron-announces-strategic-collaboration-with-parabilis-medicines-to-advance-novel-antibody-helicon-conjugates-across-multiple-therapeutic-areas/2346076

Regeneron Announces Strategic Collaboration with Parabilis Medicines to Advance Novel Antibody-Helicon™ Conjugates Across Multiple Therapeutic Areas | The Manila Times

https://www.manilatimes.net/2026/05/18/tmt-newswire/globenewswire/regeneron-announces-strategic-collaboration-with-parabilis-medicines-to-advance-novel-antibody-helicon-conjugates-across-multiple-therapeutic-areas/2346076
https://www.manilatimes.net/2026/07/02/tmt-newswire/pr-newswire/insilico-medicine-announces-collaboration-with-takeda-to-advance-strategic-ai-drug-discovery/2377211

Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery | The Manila Times

https://www.manilatimes.net/2026/07/02/tmt-newswire/pr-newswire/insilico-medicine-announces-collaboration-with-takeda-to-advance-strategic-ai-drug-discovery/2377211
https://www.finanznachrichten.de/nachrichten-2026-06/68804991-sk-pharmteco-inc-sk-pharmteco-announces-strategic-collaboration-with-orphan-therapeutics-accelerator-for-the-development-and-manufacturing-of-rare-d-399.htm

SK pharmteco Inc.: SK pharmteco Announces Strategic Collaboration with Orphan Therapeutics Accelerator for the Development and Manufacturing of Rare Disease Therapies

https://www.finanznachrichten.de/nachrichten-2026-06/68804991-sk-pharmteco-inc-sk-pharmteco-announces-strategic-collaboration-with-orphan-therapeutics-accelerator-for-the-development-and-manufacturing-of-rare-d-399.htm
https://www.manilatimes.net/2026/07/08/tmt-newswire/pr-newswire/otr-therapeutics-enters-strategic-collaboration-with-lg-chem-to-accelerate-development-of-novel-oncology-therapies/2380397

OTR Therapeutics Enters Strategic Collaboration with LG Chem to Accelerate Development of Novel Oncology Therapies | The Manila Times

https://www.manilatimes.net/2026/07/08/tmt-newswire/pr-newswire/otr-therapeutics-enters-strategic-collaboration-with-lg-chem-to-accelerate-development-of-novel-oncology-therapies/2380397
https://www.manilatimes.net/2026/06/24/tmt-newswire/pr-newswire/abbisko-therapeutics-deepens-rd-collaboration-with-lilly/2371554

Abbisko Therapeutics Deepens R&D Collaboration with Lilly | The Manila Times

https://www.manilatimes.net/2026/06/24/tmt-newswire/pr-newswire/abbisko-therapeutics-deepens-rd-collaboration-with-lilly/2371554
https://www.finanznachrichten.de/nachrichten-2026-05/68534566-delveinsight-business-research-llp-netherton-syndrome-market-set-to-expand-during-the-forecast-period-2026-2036-as-novel-therapies-enter-developme-008.htm

DelveInsight Business Research, LLP: Netherton Syndrome Market Set to Expand During the Forecast Period (2026-2036) as Novel Therapies Enter Development Pipeline | DelveInsight

https://www.finanznachrichten.de/nachrichten-2026-05/68534566-delveinsight-business-research-llp-netherton-syndrome-market-set-to-expand-during-the-forecast-period-2026-2036-as-novel-therapies-enter-developme-008.htm